acCELLapy helps clients move from planning to real-world execution by combining specialized expertise, implementation-ready assets, and hands-on support across the full cell therapy program journey.
“The acCELLapy Team, with their Cell Therapy program methodology was instrumental in providing Saint Thomas a detailed blueprint to launch our program. The key differentiator in working with acCELLapy was the deep expertise of their physicians, APPs and Cell Pharmacy-Lab advisors. The Team understood detailed nuances of building a program. Through our work with acCELLapy we developed a clear understanding of the operating and financial implications to confidently move forward. They answered our questions as well as educated our teams on what to anticipate at different stages of program maturity. Cell Therapy is the future of cancer care. If your cancer program aims to provide Cell Therapy, I highly recommend working with acCELLapy.”
A regional health system lagged in oncology and needed to evaluate a hospital-physician collaborative CAR T model with an independent practice partner.
Determine strategic fit, feasibility, and long-term economics while defining requirements across both organizations.
Conducted market analysis, requirements inventory, and base-case financial modeling, then created an implementation blueprint.
Leadership advanced the model with a clear break-even path, manageable capital profile, and a roadmap that supported one of the earliest hospital-physician ATC models.
A cell therapy manufacturer explored whether an ATC and affiliated community hospital could safely share delivery responsibilities.
Clarify capabilities, roles, risks, and readiness requirements prior to pilot execution.
Facilitated structured planning sessions, documented current-state workflows, and outlined governance and training requirements.
Produced a practical operating concept and risk checklist that validated feasibility when safeguards and role clarity are designed intentionally.
A large regional system with strong oncology services needed to evaluate adding CAR T to remain competitive and attract oncology talent.
Assess demand, readiness, required investment, and launch timeline within an integrated internal care model.
Performed market and readiness analysis, built financial models, aligned leadership on priorities, and developed a six-month implementation roadmap.
The client gained a decision-ready case and actionable launch plan showing that targeted upgrades could support a sustainable program.
If your organization is evaluating a launch, scaling an existing model, or expanding access across a broader network, acCELLapy can help you define the right path forward.
Talk with an expert